LifeVantage yesterday announced preliminary unaudited net revenue for the fourth quarter of 2009. The company anticipates net revenue of $1.6 million for the three month period ended June 30, 2009, an increase of approximately 150% from the prior three month period.

LifeVantage CEO David W. Brown was pleased with the results. He stated, “The increase in fourth quarter revenue is attributed to our launch earlier this year into network marketing as well as the addition of a team of some of the most sought after and highest producing independent distributors in the network marketing industry. We believe this team will continue to significantly impact LifeVantage’s continued expansion into the network marketing sales channel.”

LifeVantage Corp. is a science-based, natural products company dedicated to helping people reach their health and wellness goals through science-based solutions to oxidative stress. The company’s nutraceutical products, such as Protandim, are intended to deliver significant health benefits to consumers.

Protandim is a supplement intended to provide benefits to help consumers with the challenges of healthy aging. This patented antioxidant therapy works differently than other antioxidant supplements or antioxidant foods such as red wine or certain fruits. Protandim works by increasing the body’s natural antioxidant protection at the cellular level, inducing cells to produce naturally occurring protective antioxidant enzymes such as catalase, superoxide dismutase and glutathione synthase.

A peer-reviewed human clinical study showed that, after Protandim was taken for 30 consecutive days, the accumulation of lipid peroxidation products – a biochemical market of aging – was decreased by an average of 40%. Protandim is currently the subject of approximately 20 scientific studies at leading universities and research facilities.

Let us hear your thoughts below:

Last 5 posts by QualityStocks

• New Market Technology, Inc. (NWMT.PK) Announces Greenfield Partnership Program Webcast Date - March 19th, 2010
• Bovie Medical Corp. (BVX) Receives FDA Approval for New Coagulation Device - March 19th, 2010
• Integrated Environmental Technologies, Ltd. (IEVM.OB) and Benchmark Exhibit Excelyte® Performance in Fracking the Marcellus Shale - March 19th, 2010
• Cascade Technologies Corp. (CSDT.OB) is “One to Watch” - March 19th, 2010
• Pernix Group Inc. (PRXG.OB) Anticipates Enhanced Visibility and Communication through Advancement to Bulletin Board - March 19th, 2010